从“治已病”到“治欲病”：华大基因用多组学+智能化打造健康管理新范式

BGI's i99 Intelligent Health System provides smart health management solutions that help users easily interpret medical reports and develop long-term health habits.

1. After uploading medical reports, the mini-program's health assistant BOBO automatically explains technical terms like "adenomatous polyps," provides reference suggestions, supports follow-up questions, and maintains records—addressing the pain point of incomprehensible reports.

2. The system syncs with wearable devices like smartwatches to track heart rate, steps, and sleep data, generating personalized exercise recommendations and risk alerts, thereby extending health management from check-ups to daily life.

3. Using multi-omics testing technology, the system categorizes users into "pre-disease," "at-risk," and "disease" groups for stratified management, offering proactive assessments and interventions to shift from passive treatment to active prevention and make health management more sustainable.

BGI's brand strategy involves multi-channel development and product innovation aligned with health consumption trends.

1. In brand marketing, BGI has built an online ecosystem centered around its internet hospital, including self-operated stores, traditional e-commerce, and interest-based e-commerce, offering over 30 consumer products such as reproductive health tests to meet diverse user needs.

2. Product R&D focuses on trends like at-home testing (using saliva or stool samples) for convenience, with new developments in chronic disease management and cancer risk assessment to cater to growing demand for proactive health.

3. User behavior insights show rising health awareness driving integrated online-offline services; the company deepens collaborations with governments and enterprises to deploy testing services, leveraging technical credentials (e.g., 253 NMPA certifications) to enhance user trust.

Public health screening projects and policy insights reveal growth opportunities and partnership models.

1. Government-led initiatives, such as Hebei’s free genetic screening for pregnant women and Harbin’s digestive cancer screening for 2.4 million people, offer high cost-effectiveness (e.g., 1:9.79 for Down syndrome prevention), providing lessons for crisis response and supportive policies.

2. Growth markets include international collaborations, like Rwanda’s HPV testing and Thailand’s NIPT coverage under insurance; sellers can adapt localized models (100+ technology transfer projects across 36 countries) to expand business partnerships.

3. Emerging business models feature online-offline integration; sellers can engage in government or corporate collaborations, with risks including fragmented health data and opportunities in AI-multi-omics fusion to accumulate health assets.

BGI’s product design and commercial opportunities offer digital insights for manufacturers.

1. Production needs involve at-home test kits (e.g., saliva or stool samples) designed for accessibility, highlighting the importance of optimizing testing workflows and user-friendly interfaces.

2. Commercial opportunities arise from public health projects, such as screenings covering 30 million people across 20+ provinces; factories can learn from partnership models (e.g., with体检 centers, government agencies) and e-commerce applications (product listings on self-run stores).

3. Digital启示: Multi-omics and AI integration (e.g., the i99 system) demonstrate how to synthesize wearable device data; factories can adopt systemic engineering capabilities to enable customized health management product manufacturing.

Industry trends and technical solutions focus on addressing client pain points.

1. Trend: Health management is shifting from "passive treatment" to "active prevention," with multi-omics expanding application scopes and consumer markets accelerating; service providers must prioritize full-lifecycle service demands.

2. New technologies like AI-powered genetic analysis (BOBO assistant) solve clients’ difficulty understanding medical reports by offering personalized intervention advice, backed by 769 authorized patents.

3. Solution: The i99 system integrates wearable data for long-term tracking; service providers can reference BGI’s industrial practices (387 overseas certifications) to develop similar health management platforms.

Platform demands and operational management involve online-offline integration.

1. Latest platform approach: Centered on the internet hospital, BGI built a full-scope e-commerce service (self-operated stores, interest-based e-commerce) listing consumer products; platforms should optimize merchant recruitment and user operations to enhance accessibility.

2. Commercial needs: Health data silos require platforms to integrate information (e.g., syncing wearables) for personalized plans, necessitating deeper collaborations (e.g., government projects) to mitigate fragmentation risks.

3. Operations: Online-offline synergy (e.g., partnerships with体检 centers) can be enhanced by studying BGI’s technology transfer model (100+ projects) to strengthen localization and ensure service sustainability.

Industry shifts and policy implications reveal evolving business models.

1. New动向: Health management is expanding from research tools to public applications, driven by lower gene testing costs enabling large-scale screening; the industry faces a paradigm shift from "treating disease" to "managing pre-disease."

2. Policy启示: Public health projects (e.g., Hebei screening) show high cost-benefit ratios (1:9.79), suggesting policymakers advance prevention; researchers can analyze regulatory impacts of integrated medical-prevention practices (e.g., Harbin project).

3. Business models: Consumer applications (e.g., i99 system) demonstrate how AI-multi-omics can transform health data into assets, involving patent licensing (769 patents) and international cooperation exports.